摘要:
The invention relates to the method of preventing and treating sepsis using chemokines selected from mature or modified KC [SEQ ID NO: 1], gro&agr;[SEQ ID NO:2], gro&bgr;[SEQ ID NO: 3] or gro&ggr;[SEQ ID NO: 4] or multimers thereof, alone or in conjunction with an anti-infective agent. This invention also relates to a new gro&bgr; dimer chemokine.
摘要翻译:本发明涉及使用选自成熟或修饰的KC [SEQ ID NO:1],groalpha [SEQ ID NO:2],grobeta [SEQ ID NO:3]或grogamma [SEQ ID NO:1]的趋化因子来预防和治疗败血症的方法 :4]或多聚体,单独或与抗感染剂联合使用。 本发明还涉及一种新的骨髓二聚体趋化因子。
摘要:
The invention relates to the method of preventing and treating sepsis using chemokines selected from mature or modified KC [SEQ ID NO: 1], gro.alpha. [SEQ ID NO:2], gro.beta. [SEQ ID NO: 3] or gro.gamma. [SEQ ID NO: 4] or multimers thereof, alone or in conjunction with an anti-infective agent. This invention also relates to a new gro.beta. dimer chemokine.
摘要翻译:本发明涉及使用选自成熟或修饰的KC [SEQ ID NO:1],groα[SEQ ID NO:2],groβ[SEQ ID NO:3]或groγγ的趋化因子来预防和治疗败血症的方法。 SEQ ID NO:4]或其多聚体,单独或与抗感染剂联合使用。 本发明还涉及新的蛋白质二聚体趋化因子。
摘要:
The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.
摘要:
The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.